Olanzapine/samidorphan
id:
olanzapine-samidorphan-298-16864387
title:
Olanzapine/samidorphan
text:
Olanzapine/samidorphan, sold under the brand name Lybalvi, is a fixed-dose combination medication for the treatment of schizophrenia and bipolar I disorder. It contains olanzapine, an atypical antipsychotic, and samidorphan, an opioid antagonist. Samidorphan reduces the weight gain associated with olanzapine while still allowing olanzapine to exert its therapeutic effect. The formulation was approved for medical use in the United States in May 2021.
brand slug:
wiki
category slug:
encyclopedia
description:
Combination drug
original url:
https://en.wikipedia.org/wiki/Olanzapine/samidorphan
date created:
date modified:
2023-11-12T00:59:14Z
main entity:
{"identifier":"Q39049951","url":"https://www.wikidata.org/entity/Q39049951"}
image:
fields total:
13
integrity:
14